Cite
Perioperative systemic chemo‐immunotherapy for upper urinary tract urothelial carcinoma
MLA
Jun Eul Hwang, et al. Perioperative Systemic Chemo‐immunotherapy for Upper Urinary Tract Urothelial Carcinoma. Mar. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....933a42aee1560d87e097dd0023854ee2&authtype=sso&custid=ns315887.
APA
Jun Eul Hwang, Vikram M. Narayan, Philipp Dahm, Philippe E. Spiess, Jae Hung Jung, Eu Chang Hwang, Myung Ha Kim, & Niranjan J. Sathianathen. (2020). Perioperative systemic chemo‐immunotherapy for upper urinary tract urothelial carcinoma.
Chicago
Jun Eul Hwang, Vikram M. Narayan, Philipp Dahm, Philippe E. Spiess, Jae Hung Jung, Eu Chang Hwang, Myung Ha Kim, and Niranjan J. Sathianathen. 2020. “Perioperative Systemic Chemo‐immunotherapy for Upper Urinary Tract Urothelial Carcinoma,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....933a42aee1560d87e097dd0023854ee2&authtype=sso&custid=ns315887.